A tussle over the control of resources, overlapping tasks, and a budget that did not match with the activities, might have cost the country the much needed Global Fund money for the purchase of the life prolonging anti-retro viral drugs.
The country’s appeal to the Global Fund for HIV/AIDS, Tuberculosis, and Malaria for Round 9 funds totalling 73 million for HIV/AIDS programmes was rejected, sending the country into a serious funding crisis for its ARV programme.










